LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/David Hook Joins Biorez as VP of Sales
Company News

David Hook Joins Biorez as VP of Sales

May 21, 2021 1 min read Premium comments

Advertisement

Secondary#biorez#davidhook

David Hook has joined New Haven, Connecticut-based Biorez Inc. as its vice president of sales.

Hook has over 20 years of worldwide medical device experience. For 16 years he worked at Mitek Sports Medicine (part of the DePuy Synthes Companies of Johnson & Johnson) where he advanced from sales representative to worldwide director of professional education and market development. Since then, Hook has worked in leadership roles as director of market development at Conventus Orthopaedics, Trice Medical, and Rotation Medical. His most recent position before joining Biorez was as vice president of sales at Xiros North America.

Biorez Founder and CEO Kevin Rocco expressed excitement about Hook joining the company: “David [Hook] is a talented commercial executive with extensive relationships and experience launching new disruptive technologies in sports medicine, and we are excited to welcome him to our team.”

Rocco continued, “David [Hook] was also a key member of Rotation Medical, where he drove market adoption and clinical education of their regenerative implant for rotator cuff repair, from the first surgical case post-FDA clearance through a successful acquisition by Smith & Nephew.”

Founded in 2016, Biorez is focused on treatments for tendon and ligament injuries. Its flagship product is the BioBrace™ Implant. Per its website, the BioBrace Implant is a “bioinductive scaffold that is intended to reinforce soft tissue where weakness exists, and promote soft tissue healing.” It can be used for “reinforcement of soft tissues that are repaired by suture or suture anchors, during tendon repair surgery.” Last month, it received FDA 510(k) clearance.

Hook remarked, “Implants that are bioinductive while providing structure for healing tissues during the repair or reconstruction continuum is the natural progression with this type of technology and I am looking forward to working with our surgeons to deliver the best-in-class implant for their practice and their patients.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy